Skip to the page

Data / Form D filings / Anserine Labs, Inc.

Anserine Labs, Inc.: Form D filing

Anserine Labs, Inc., a technology company in London, United Kingdom, filed a Form D with the SEC in 2025. The latest, on August 28, 2025, reports $3.4 million sold of a $3.5 million offering to 21 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
26 WESTWOOD HOUSE, 47 OLD DEVONSHIRE ROAD, London, United Kingdom, SW12
Phone
44 7584 887239
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2025
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2083708

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 28, 2025New notice$3,500,000$3,439,997$60,00321Aug 13, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Joshua WatzmanDirector, Promoter
Jackson GabbardExecutive Officer, Director, Promoter
Julien CodorniouDirector
David MillerExecutive Officer, Director, Promoter

Every Form D from the week of Aug 25, 2025 · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Anserine Labs, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.